Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4. This signals a small update to the page metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-18T13:53:35.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Changed the Age eligibility in the study to '18 Years and older' from the previous '18 Years to 120 Years', removing the upper age limit and expanding which adults may enroll in the trial.
    Difference
    0.2%
    Check dated 2026-05-11T12:18:14.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Changes to the Chilean location listing replace regional labels in Spanish with corresponding region labels in English, while preserving the same locations and site identifiers (e.g., Temuco and Viña del Mar). The page revision/version string was updated accordingly.
    Difference
    0.5%
    Check dated 2026-04-27T07:38:21.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T08:53:03.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T01:47:39.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Page revision updated to v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T12:48:18.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.